Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
59%
Malignant Neoplasm
57%
Epidermal Growth Factor Receptor
50%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
46%
Lung Adenocarcinoma
38%
Chronic Obstructive Lung Disease
36%
Progression Free Survival
28%
Breast Cancer
25%
Disease
24%
Pemetrexed
24%
Lung Cancer
23%
Neoplasm
21%
Reactive Oxygen Metabolite
20%
Protein Mcl 1
18%
Histone Methyltransferase
16%
Vitamin D Deficiency
16%
Hypovitaminosis D
16%
Squamous Cell Lung Carcinoma
15%
Adult Respiratory Distress Syndrome
15%
Lung Emphysema
15%
Mycobacterium Avium Complex
15%
Death Receptor 5
15%
Activating Transcription Factor 4
15%
Epidermal Growth Factor Receptor Kinase Inhibitor
15%
Elastase
15%
Overall Survival
13%
Cytotoxicity
13%
Hospital Mortality
13%
Protein Tyrosine Kinase Inhibitor
13%
Combination Therapy
11%
Liver Cell Carcinoma
11%
Erlotinib
11%
Gefitinib
11%
Pleura Effusion
10%
Lung Disease
10%
Histone
10%
Anticarcinogen
10%
Gemcitabine
9%
Emphysema
9%
Cyclin Dependent Kinase 9
9%
Leukemia
9%
Afatinib
8%
Pancreas Cancer
8%
Drug Repositioning
8%
Docetaxel
8%
Lysine
8%
Anaplastic Lymphoma Kinase
7%
Riluzole
7%
Rifampicin
7%
Cohort Study
7%
Medicine and Dentistry
Non Small Cell Lung Cancer
51%
Epidermal Growth Factor Receptor
47%
Lung Cancer
40%
Lung Adenocarcinoma
31%
Chronic Obstructive Pulmonary Disease
26%
Cancer Cell
24%
Epidermal Growth Factor Receptor Kinase Inhibitor
24%
Progression Free Survival
21%
Hazard Ratio
21%
Computer Assisted Tomography
17%
Tyrosine-Kinase Inhibitor
16%
Programmed Cell Death
16%
Vitamin D Deficiency
16%
Hypovitaminosis D
16%
Lung Nodule
15%
Acute Respiratory Distress Syndrome
15%
Neoplasm
14%
Overall Survival
14%
Malignant Neoplasm
13%
Disease
13%
Hospital Mortality
12%
Lung
11%
Smoking
11%
Erlotinib
11%
Gefitinib
11%
Pleura Effusion
10%
Prognostic Factor
10%
Silo-Filler's Disease
10%
Diagnosis
10%
Proportional Hazards Model
10%
Lung Biopsy
9%
Cell Death
9%
Metastatic Carcinoma
9%
Exon
9%
In Vitro
8%
Unfolded Protein Response
8%
down Regulation
8%
Drug Repositioning
8%
Docetaxel
8%
Odds Ratio
8%
Spirometry
8%
Outpatient
8%
Idiopathic Pulmonary Fibrosis
7%
Thorax Radiography
7%
Survivin
7%
Skin Metastasis
7%
Tumor Angiogenesis
7%
Connective Tissue Disease
7%
Protein Intake
7%
COVID-19
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Tumor Necrosis Factor
70%
down Regulation
33%
TRAIL
31%
Cell Death
20%
Small Molecule
18%
Unfolded Protein Response
18%
Activating Transcription Factor 4
15%
Myeloid
15%
Inhibitor of Apoptosis
15%
Euchromatin
15%
Epidermal Growth Factor Receptor
15%
Apoptosis
12%
Histone Methyltransferase
12%
Upregulation
11%
Endoplasmic Reticulum Stress
10%
Sensitization
9%
Gemcitabine
9%
Lysine
8%
Circulating Tumor DNA
7%
Adenine
7%
Genome Wide Association Study
7%
Pharmacogenetic Testing
7%
Progression Free Survival
7%
Calcium Cell Level
7%
X-Linked Inhibitory Apoptosis Protein
7%
Daunorubicin
7%
Survival Rate
7%
Calcium Mobilization
7%
Receptor Tyrosine Kinase Inhibitors
7%
Survivin
7%
Tumor Volume
7%
Electronic Health Record
7%
Gene Locus
7%
CRISPR
7%
Drug Sensitivity
7%
Smoking
7%
Airflow
7%
Angiogenesis
7%
Genome-Wide Association Study
7%
Methyltransferase
7%
Histone Deacetylase
7%
Cyclin-Dependent Kinase 7
7%
Insulin-Like Growth Factor 1 Receptor
7%
Ciclosporin
7%
SOX2
7%
Guanosine Triphosphate
7%
Transcriptomics
7%
Bcl-2-Associated X Protein
7%
B Cell
7%